Navigation Links
Small Implant To Check On Cancer

Scientists from US are refining measures to use microscopic particles that will stick to chemicals in cancer cells// and will show up during scans. This technique is yet to be tested on humans. These implants could let the doctor know about the extent of spread of cancer cells and the effect of drugs on them.

The current procedure of scans and blood test do not highlight the extent of drug penetration in to the tumor. For doctors, it is an uphill task to find out about the appropriate dose of a cancer drug or its efficacy.

Microscopic nanoparticles made out of iron oxide and coated with a sugar called dextran are being used in the project undertaken by a team from Massachusetts Institute of Technology (MIT). These tiny particles are coated with antibodies, immune system components which can attach itself to specific molecules inside cancer cells. These particles cluster together whenever the target molecules are present which can be spotted while MRI scanning.

The tiny silicon container that houses the nanoparticles are important as it permits the chemical reaction to take place without nanoparticles getting dispersed out of the cancer tumor. This enables the doctor to have long term and detailed view of cancer conditions. Currently the team is perfecting a few tests which can be tried out in humans. The team is optimistic that the particles can be grouped together by human chorionic gonadotrophin, which is a hormone produced by few cancers and in pregnant women.

Cancer Research UK medical director Professor John Toy while welcoming these tests said that there is a long way for such tests to reach its desirable results.


JYT
'"/>




Page: 1

Related medicine news :

1. Smallpox as Biological Weapons?
2. Is Smallpox Threat Real ?
3. Smallpox Vaccine May Help Fight Cervical Cancer
4. Smallpox Would Spread Rapidly
5. Drug Firm Offers to Donate Smallpox Vaccine
6. Small aneurysms best left untouched
7. Small lumps in breast if not treated may cause long-term harm
8. Third generation Small pox vaccine from Cell-culture
9. CT Scans Said to Accurately Detect Small Cancers
10. Brain of Cocaine Addicts Smaller In Size
11. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology: